Dr. Hannah Sophie Berman, MD

Dr. Berman practices at Scripps Clinic in Encinitas, California.

Dr. Berman's NPI, 1952987349, was assigned on March 24, 2021. Dr. Berman graduated from David Geffen School of Medicine at UCLA in 2021. Dr. Berman holds Florida license ME159873.

Dr. Berman's primary practice is Scripps Clinic, at 326 Santa Fe Dr, Encinitas, CA 92024 in San Diego County. The practice phone is (858) 554-9100.

Dr. Berman's primary practice is Scripps Clinic in Encinitas, California. The medical group on file is Scripps Clinic Medical Group. Dmand AI also links Dr. Berman to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Berman practices. Vendor and product names are available with a free account.

Dermatology is Dr. Berman's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Dr. Berman's licenses on file in 3 states: Florida, California and Minnesota.

CMS data shows 564 Medicare services from Dr. Berman across 10 procedure codes in 2024, for 187 Medicare patients. Medicare paid $24,662 for them. Every service was in an office.

CMS counts 187 Medicare patients who saw Dr. Berman in 2024. The largest group is 65 to 74, with 87 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Berman's median patient age at 56, with 51% women.

In 2024, Dr. Berman wrote 184 Medicare Part D claims for 72 patients. 91% of them were for generic drugs. CMS names the drug for 103 of them, across 5 drugs with 11 or more claims each, at $3,193 in total drug cost. In 2023, CMS named 108 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Berman for performance year 2024, reported as part of a group. Dr. Berman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 52 procedures of removal of skin lesions by Dr. Berman, more than 72% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Berman, published from 2019 to 2024. 2020 was the busiest year, with 3. The most frequent topics are Skin Neoplasms, Acne Vulgaris and Carcinoma, Basal Cell. Dr. Berman has published most often in Dermatol Surg. Dr. Berman's most frequent co-authors are Catherine Abbie Degesys, MD, Carol Erin Cheng, MD and Marcia Hogeling, MD.

CMS Open Payments shows 7 general payments to Dr. Berman from 5 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 70% of the total. Janssen Pharmaceuticals, Inc paid the most, $318.

Dr. Berman graduated from David Geffen School of Medicine at UCLA in 2021.

Dr. Berman is in network with 3 carriers, including Elevance, Blue Cross Blue Shield of Michigan and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.